Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Oxalobacter formigenes-derived factor receptor is a putative cell-surface receptor located on the apical membrane of intestinal epithelial cells that mediates the action of secretagogues produced by the gut commensal bacterium Oxalobacter formigenes (Arvans et al., 2017). These secretagogues, recently identified as Sel1-like proteins and specific derived peptides known as P8 and P9, trigger a signaling cascade involving Protein Kinase A (PKA) upon binding to the receptor (Arvans et al., 2023). Activation of this pathway leads to the upregulation and increased apical membrane expression of the oxalate transporters SLC26A6 and SLC26A2 (Hassan, Grantome). This process enhances enteric oxalate secretion, which effectively reduces the systemic absorption of oxalate and its subsequent excretion in the urine. Consequently, this receptor is a significant therapeutic target for the treatment of hyperoxaluria and the prevention of calcium oxalate kidney stones. While the exact molecular identity of the receptor remains to be fully characterized, evidence suggests it may belong to the G protein-coupled receptor (GPCR) family and potentially involve adenosine receptor signaling pathways (Musch et al., 2023).
Agonism of the receptor triggers a PKA-dependent signaling pathway that increases the apical membrane recruitment and transport activity of SLC26A6 and SLC26A2, thereby stimulating intestinal oxalate secretion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxalobacter formigenes-derived factor receptor.